UCLA HIV Prevention and Treatment Program
UCLA AIDS Prevention and Treatment Clinical Trials Unit
This program offers clinical research testing new HIV treatments, prevention methods, and vaccines for adults living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11456948 on NIH RePORTER |
What this research studies
You can join clinical research run by a UCLA team and partner clinics in Los Angeles, Brazil, and Argentina that tests new HIV treatments, prevention approaches, and vaccines. The unit has an administrative core and multiple clinical sites staffed by experienced investigators and research teams. They design and run therapeutic and prevention trials, enroll participants, collect medical data and samples, and provide study follow-up. Studies include medication trials, prevention strategies like PrEP, vaccine research, and observational work across diverse populations.
Who could benefit from this research
Good fit: Ideal candidates are adults (often 21 years and older) living with HIV or adults at risk of HIV who meet each study's specific eligibility requirements and can attend a participating site.
Not a fit: People who do not meet a trial's eligibility criteria, are outside the allowed age range, have excluded health conditions, or cannot travel to a study site may not directly benefit.
Why it matters
Potential benefit: If successful, this work could lead to better HIV treatments, more effective prevention options (including vaccines), and improved care for people with or at risk for HIV.
How similar studies have performed: Many prior clinical trials have produced effective HIV treatments and prevention methods such as antiretroviral therapy and PrEP, although vaccine development has been more difficult.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Landovitz, Raphael J — University of California Los Angeles
- Study coordinator: Landovitz, Raphael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.